News

As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...

Taiwan, 31st July 2023: Bora Pharmaceuticals, a leading contract development and manufacturing organization (CDMO), is pleased to announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of...

Telemedicine has undeniably transformed the landscape of healthcare delivery. This innovative approach has created a bridge, connecting patients and healthcare professionals in ways traditional methods couldn’t. It provides efficiency and access, demonstrating its expansive reach and undeniable value in...

Envirotainer is a specialist in secure cold chain solutions for the shipment of temperature-sensitive pharmaceuticals. va-Q-tec is a pioneer in the area of thermal insulations and thermal energy efficiency and offers a wide range of temperature-controlled packaging solutions, that...

July 27, 2023 Bio-Asia Taiwan Exhibition Taipei, Taiwan Bora has been awarded "Outstanding Company of the Year" by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short...

Government programs and health insurance acknowledge Applied Behavior Analysis (ABA) as a necessary medical treatment. Still, in the beginning, no specific billing codes had been applied to ABA. Due to this, ABA billers and therapists needed to use generic...

Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing facility in Turku, Finland. This investment reflects Biovian’s commitment to meeting the growing demand for...